Smith Sean Michael - Insider Non-Derivative Transactions at Neoleukin Therapeutics, Inc. (NLTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 11, 2023, Smith Sean Michael's relationship to Neoleukin Therapeutics, Inc. (NLTX) is Officer (Interim CFO, Prin Acct Off), and currently has 21,637 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NLTX insiders.
Data Source: SEC.
Smith Sean Michael - Insider Non-Derivative Transactions of NLTX Common Stock
Smith Sean Michael - Insider Non-Derivative Transactions at NLTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 12, 2023 | Sell -- (Common Stock) | 1323 | 0.62 | 21637 |
| Aug 11, 2023 | M -- (Common Stock) | 5000 | 0 | 22960 |
| Feb 3, 2023 | Sell -- (Common Stock) | 3316 | 0.6 | 15960 |
| Feb 2, 2023 | M -- (Common Stock) | 12500 | 0 | 19276 |